Literature DB >> 16552814

Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina.

Luis Orlando Pérez1, Martin Carlos Abba, Fernando Noel Dulout, Carlos Daniel Golijow.   

Abstract

AIM: To evaluate the potential association between p53 codon 72 polymorphism and sporadic colorectal adenocarcinoma development,and human papillomavirus (HPV) infection.
METHODS: One-hundred and nine controls and 53 patients with colon cancer from the city of La Plata, Argentina were analyzed. p53 codon 72 genotypes and HPV infection were identified using allele-specific polymerase chain reaction and nested polymerase chain reaction, respectively.
RESULTS: The differences in the distribution of p53 codon 72 polymorphism between the cases and controls were statistically significant. The arginine allele had a prevalence of 0.65 in controls and 0.77 in cases. The corresponding odds ratio for the homozygous arginine genotype was 2.08 (95% CI, 1.06-4.05; P<0.05). Lack of association was found between p53 polymorphism and HPV infection in the set of adenocarcinomas.
CONCLUSION: The findings of the present study indicate that p53 codon 72 arginine homozygous genotype may represent a genetic predisposing factor for colon cancer development. However,further studies are needed in order to elucidate the role of p53 codon 72 polymorphism in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552814      PMCID: PMC4124323          DOI: 10.3748/wjg.v12.i9.1426

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  p53 codon 72 polymorphism and risk of cervical cancer.

Authors:  José M Ojeda; Sandra Ampuero; Patricio Rojas; Rodrigo Prado; Jorge E Allende; Sara A Barton; Ranajit Chakraborty; Francisco Rothhammer
Journal:  Biol Res       Date:  2003       Impact factor: 5.612

2.  Two polymorphic variants of wild-type p53 differ biochemically and biologically.

Authors:  M Thomas; A Kalita; S Labrecque; D Pim; L Banks; G Matlashewski
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 3.  Screening for colorectal cancer.

Authors:  G S Gazelle; P M McMahon; F J Scholz
Journal:  Radiology       Date:  2000-05       Impact factor: 11.105

4.  P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection.

Authors:  N Sayhan; H Yazici; M Budak; O Bitisik; N Dalay
Journal:  Res Commun Mol Pathol Pharmacol       Date:  2001-07

5.  Human papillomavirus type 18 in colorectal cancer.

Authors:  Y M Lee; S Y Leu; H Chiang; C P Fung; W T Liu
Journal:  J Microbiol Immunol Infect       Date:  2001-06       Impact factor: 4.399

6.  Detection of c-erbB-2 gene amplification in cervical scrapes positive for human papillomavirus (HPV).

Authors:  C D Golijow; M Abba; S A Mourón; M A Gómez; A Güercci; F N Dulout
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

7.  Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay.

Authors:  Paola Monti; Paola Campomenosi; Yari Ciribilli; Raffaella Iannone; Anna Aprile; Alberto Inga; Mitsuhiro Tada; Paola Menichini; Angelo Abbondandolo; Gilberto Fronza
Journal:  Oncogene       Date:  2003-08-14       Impact factor: 9.867

8.  The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.

Authors:  Anita Langerød; Ida R K Bukholm; André Bregård; Per Eystein Lønning; Tone Ikdal Andersen; Torleiv O Rognum; Gunn Iren Meling; Ragnhild A Lothe; Anne-Lise Børresen-Dale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

Review 9.  The genetics of colorectal cancer.

Authors:  Paula M Calvert; Harold Frucht
Journal:  Ann Intern Med       Date:  2002-10-01       Impact factor: 25.391

10.  The p53 codon 72 genotypes in HPV infection and cervical disease.

Authors:  Martín C Abba; Luciana M Villaverde; María A Gómez; Fernado N Dulout; Martín R Laguens; Carlos D Golijow
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-07-01       Impact factor: 2.435

View more
  24 in total

1.  p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population.

Authors:  Hye-Rim Song; Sun-Seog Kweon; Hee Nam Kim; Jin-Mei Piao; Woo-Jun Yun; Jin-Su Choi; Jun-Eul Hwang; Ju-Young Yoon; Hyeong-Rok Kim; Young-Kyu Park; Soo-Hyun Kim; Yoo-Duk Choi; Min-Ho Shin
Journal:  Gastric Cancer       Date:  2011-04-02       Impact factor: 7.370

2.  TP53 gene polymorphism: importance to cancer, ethnicity and birth weight in a Brazilian cohort.

Authors:  Helena S Thurow; Ricardo Haack; Fernando P Hartwig; Isabel O De Oliveira; Odir A Dellagostin; Denise P Gigante; Bernardo L Horta; Tiago Collares; Fabiana K Seixas
Journal:  J Biosci       Date:  2011-12       Impact factor: 1.826

3.  TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.

Authors:  Natalia Volodko; Mohamed Salla; Bertus Eksteen; Richard N Fedorak; Hien Q Huynh; Shairaz Baksh
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

4.  TP53 alterations and colorectal cancer predisposition in south Indian population: a case-control study.

Authors:  Gopi Krishna Singamsetty; Sravanthi Malempati; Srichandana Bhogadhi; Ravinder Kondreddy; Suresh Govatati; Naveen Kumar Tangudu; Sowdamani Govatati; Anil Kumar kuraganti; Manjula Bhanoori; Kondaiah Kassetty
Journal:  Tumour Biol       Date:  2013-10-26

5.  TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.

Authors:  Rym Abderrahmane; Lotfi Louhibi; Fatima Zohra Moghtit; Amina Boubekeur; Khedidja Benseddik; Abdellah Boudjema; Fouzia Benrrahal; Meriem Aberkane; Mostefa Fodil; Nadhira Saidi-Mehtar
Journal:  Pathol Oncol Res       Date:  2014-12-24       Impact factor: 3.201

6.  TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Jing-Jun Wang; Yuan Zheng; Liang Sun; Li Wang; Peng-Bo Yu; Jian-Hua Dong; Lei Zhang; Jing Xu; Wei Shi; Yu-Chun Ren
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

7.  Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression.

Authors:  Zhong-Zheng Zhu; Bing Liu; Ai-Zhong Wang; Hang-Ruo Jia; Xia-Xiang Jin; Xiang-Lei He; Li-Fang Hou; Guan-Shan Zhu
Journal:  J Zhejiang Univ Sci B       Date:  2008-11       Impact factor: 3.066

Review 8.  Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas.

Authors:  Zahra Montazeri; Evropi Theodoratou; Christine Nyiraneza; Maria Timofeeva; Wanjing Chen; Victoria Svinti; Shanya Sivakumaran; Gillian Gresham; Laura Cubitt; Luis Carvajal-Carmona; Monica M Bertagnolli; Ann G Zauber; Ian Tomlinson; Susan M Farrington; Malcolm G Dunlop; Harry Campbell; Julian Little
Journal:  Int J Epidemiol       Date:  2015-10-07       Impact factor: 7.196

9.  Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs.

Authors:  Helena S Thurow; Fernando P Hartwig; Clarice S Alho; Deborah S B S Silva; Rafael Roesler; Ana Lucia Abujamra; Caroline Brunetto de Farias; Algemir Lunardi Brunetto; Bernardo L Horta; Odir A Dellagostin; Tiago Collares; Fabiana K Seixas
Journal:  Mol Biol Rep       Date:  2013-05-10       Impact factor: 2.316

10.  Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.

Authors:  Ten-i Godai; Tetsuji Suda; Nobuhiro Sugano; Kazuhito Tsuchida; Manabu Shiozawa; Hironobu Sekiguchi; Akiko Sekiyama; Mitsuyo Yoshihara; Shoichi Matsukuma; Yuji Sakuma; Eiju Tsuchiya; Yoichi Kameda; Makoto Akaike; Yohei Miyagi
Journal:  BMC Cancer       Date:  2009-12-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.